Back
Marker Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
24
MRKR
Marker Therapeutics, Inc.
Last Price:
$1.43
Seasonality Move:
11.17%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and MRKR is experiencing slight buying pressure.
Marker Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.65 | Sell |
| 20-day SMA: | 1.78 | Sell |
| 50-day SMA: | 1.61 | Sell |
| 200-day SMA: | 1.31 | Buy |
| 8-day EMA: | 1.46 | Buy |
| 20-day EMA: | 1.02 | Buy |
| 50-day EMA: | 0.54 | Buy |
| 200-day EMA: | 0.16 | Buy |
Marker Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.43 | Buy |
| Relative Strength Index (14 RSI): | 41.35 | Sell |
| Chaikin Money Flow: | 96711 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.6 - 2.02) | Sell |
| Bollinger Bands (100): | (0.92 - 1.66) | Buy |
Marker Therapeutics, Inc. Technical Analysis
| Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Marker Therapeutics, Inc. Stock
Is Marker Therapeutics, Inc. Stock a Buy?
-
Marker Therapeutics, Inc. share price is 1.46 while MRKR 8-day simple moving average is 1.65, which is a Sell signal.
-
The stock price of MRKR is 1.46 while Marker Therapeutics, Inc. 20-day SMA is 1.78, which makes it a Sell.
-
Marker Therapeutics, Inc. 50-day simple moving average is 1.61 while MRKR share price is 1.46, making it a Sell technically.
-
MRKR stock price is 1.46 and Marker Therapeutics, Inc. 200-day simple moving average is 1.31, creating a Buy signal.
MRKR Technical Analysis vs Fundamental Analysis
Sell
24
Marker Therapeutics, Inc. (MRKR)
is a Sell
Is Marker Therapeutics, Inc. a Buy or a Sell?
-
Marker Therapeutics, Inc. stock is rated a SellThe current Marker Therapeutics, Inc. [MRKR] share price is $1.46. The Score for MRKR is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Marker Therapeutics, Inc. Stock Info
Market Cap:
24.3M
Price in USD:
1.46
Share Volume:
440.6K
Marker Therapeutics, Inc. 52-Week Range
52-Week High:
4.07
52-Week Low:
0.81
Sell
24
Marker Therapeutics, Inc. (MRKR)
is a Sell
Marker Therapeutics, Inc. Share Price Forecast
-
What is the Marker Therapeutics, Inc. stock price today?The Marker Therapeutics, Inc. stock price is 1.46 USD today.
-
Will MRKR stock go up or go down?Marker Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Marker Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Marker Therapeutics, Inc. is overvalued.
Is Marker Therapeutics, Inc. Stock a Buy?
-
Marker Therapeutics, Inc. share price is 1.46 while MRKR 8-day exponential moving average is 1.46, which is a Buy signal.
-
The stock price of MRKR is 1.46 while Marker Therapeutics, Inc. 20-day EMA is 1.02, which makes it a Buy.
-
Marker Therapeutics, Inc. 50-day exponential moving average is 0.54 while MRKR share price is 1.46, making it a Buy technically.
-
MRKR stock price is 1.46 and Marker Therapeutics, Inc. 200-day simple moving average is 0.16, creating a Buy signal.
Fundamental Analysis of Marker Therapeutics, Inc.
Is Marker Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.35 per share.
Technical Analysis of Marker Therapeutics, Inc.
Should I short Marker Therapeutics, Inc. stock?
-
MRKR Moving Average Covergence Divergence (MACD) indicator is 0.43, suggesting Marker Therapeutics, Inc. is a Buy
-
Marker Therapeutics, Inc. Relative Strength Index (RSI) is 41.35, which suggest Marker Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Marker Therapeutics, Inc. is (1.6 - 2.02), which suggest Marker Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Marker Therapeutics, Inc. is (0.92 - 1.66), which suggest Marker Therapeutics, Inc. is a Buy
* Marker Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.